Skip to main content
SpringerLink
Log in

Pityriasis Rosea

  • Chapter
European Handbook of Dermatological Treatments

  • 217 Accesses

Abstract

Pityriasis rosea (PR) is a common, acute, or subacute self-limited papulosquamous skin disease. Approximately 1–2 % of new dermatological patients are affected by PR. PR affects mainly children, adolescents, and young adults. PR usually remits within 3–6 weeks. Viral etiology of PR is probable. Asymptomatic and mild cases may be left untreated. If itch is important, topical corticosteroids are indicated. Phototherapy (UVB or UVA1) may be useful in the treatment. High-dose oral acyclovir, if introduced early in the course of PR, may reduce the disease duration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Alzolibani AA, Zedan K. Macrolides in chronic inflammatory skin disorders. Mediators Inflamm. 2012;2012:159354. doi:10.1155/2012/159354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Browning JC. An update on pityriasis rosea and other similar childhood exanthems. Curr Opin Pediatr. 2009;21:481–5.

    Article  Google Scholar 

  • Chuh AA, Dofitas BL, Comisel GG, Reveiz L, Sharma V, Garner SE, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007;(2):CD005068.

    Google Scholar 

  • Drago F, Rebora A. Treatments for pityriasis rosea. Skin Therapy Lett. 2009;14:6–7.

    CAS  PubMed  Google Scholar 

  • Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82–5.

    Article  Google Scholar 

  • Gambichler T, Terras S, Kreuter A. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies. Clin Dermatol. 2013;31:438–54.

    Article  Google Scholar 

  • Rassai S, Feily A, Sina N, Abtahian S. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. J Eur Acad Dermatol Venereol. 2011;25:24–6.

    Article  CAS  Google Scholar 

  • Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpesviruses: facts and controversies. Clin Dermatol. 2010;28:497–501.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatovenereology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

    Milos Nikolic

Authors
  1. Milos Nikolic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Milos Nikolic .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Andreas Syggros Hospital University of Athens, Athens, Greece

    Andreas D. Katsambas  & Clio Dessinioti  & 

  2. University of Rome “G. Marconi”, Rome, Italy

    Torello M. Lotti

  3. Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR), Rome, Italy

    Torello M. Lotti

  4. Unit of Dermatology, University of Pisa, Pisa, Italy

    Angelo Massimiliano D’Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nikolic, M. (2015). Pityriasis Rosea. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_76

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_76

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation